IS8337A - Efnablanda sem felur í sér rósiglítasón og metformín - Google Patents

Efnablanda sem felur í sér rósiglítasón og metformín

Info

Publication number
IS8337A
IS8337A IS8337A IS8337A IS8337A IS 8337 A IS8337 A IS 8337A IS 8337 A IS8337 A IS 8337A IS 8337 A IS8337 A IS 8337A IS 8337 A IS8337 A IS 8337A
Authority
IS
Iceland
Prior art keywords
metformin
preparation containing
containing rosiglitazone
rosiglitazone
preparation
Prior art date
Application number
IS8337A
Other languages
English (en)
Other versions
IS2745B (is
Inventor
John Coles Peter
Colin Mackenzie Donald
Norman Mudd Jnr Paul
Original Assignee
Sb Pharmco Puerto Rico Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27840010&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS8337(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sb Pharmco Puerto Rico Inc. filed Critical Sb Pharmco Puerto Rico Inc.
Publication of IS8337A publication Critical patent/IS8337A/is
Publication of IS2745B publication Critical patent/IS2745B/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IS8337A 2003-08-11 2006-03-02 Aðferð og tilbúin mjölblanda til framleiðslu á brauði með auknu efnisjafnvægi, sem gott er að sneiða niður IS2745B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0318824.0A GB0318824D0 (en) 2003-08-11 2003-08-11 Novel composition
PCT/EP2004/008970 WO2005013956A1 (en) 2003-08-11 2004-08-09 Novel composition comprising rosiglitazone and another antidiabetic agent

Publications (2)

Publication Number Publication Date
IS8337A true IS8337A (is) 2006-03-02
IS2745B IS2745B (is) 2011-08-15

Family

ID=27840010

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8337A IS2745B (is) 2003-08-11 2006-03-02 Aðferð og tilbúin mjölblanda til framleiðslu á brauði með auknu efnisjafnvægi, sem gott er að sneiða niður

Country Status (36)

Country Link
US (1) US20080206336A1 (is)
EP (1) EP1663191B1 (is)
JP (1) JP4714147B2 (is)
KR (1) KR20060071396A (is)
CN (2) CN102397551A (is)
AP (1) AP2006003489A0 (is)
AR (1) AR045230A1 (is)
AT (1) ATE455542T1 (is)
AU (1) AU2004262933B2 (is)
BR (1) BRPI0413419A (is)
CA (1) CA2534480A1 (is)
CY (1) CY1109923T1 (is)
DE (1) DE602004025257D1 (is)
DK (1) DK1663191T3 (is)
EA (2) EA011550B1 (is)
EC (1) ECSP066338A (is)
ES (1) ES2339554T3 (is)
GB (1) GB0318824D0 (is)
HR (1) HRP20100160T1 (is)
IL (1) IL173177A0 (is)
IS (1) IS2745B (is)
MA (1) MA27996A1 (is)
MX (1) MXPA06001629A (is)
MY (1) MY151053A (is)
NO (1) NO20061161L (is)
NZ (1) NZ544632A (is)
OA (1) OA13233A (is)
PE (1) PE20050357A1 (is)
PL (1) PL1663191T3 (is)
PT (1) PT1663191E (is)
SG (1) SG165178A1 (is)
SI (1) SI1663191T1 (is)
TW (1) TW200517146A (is)
UA (1) UA82537C2 (is)
UY (1) UY28461A1 (is)
WO (1) WO2005013956A1 (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125516A (en) * 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
JP2007512350A (ja) * 2003-11-25 2007-05-17 エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド カルベジロール組成物の治療および送達方法
CA2731008A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
WO2011161521A1 (en) * 2010-06-21 2011-12-29 Lupin Limited Compositions comprising metformin and rosiglitazone
CN103153288B (zh) * 2010-07-09 2017-02-15 詹姆斯·特林卡·格林 用于包括瑞格列净的短半衰期药物的组合立即/延迟释放递送系统
CN105663130B (zh) * 2011-04-15 2019-08-09 江苏豪森药业集团有限公司 一种具有第一和第二活性药物的制剂
CN118001246A (zh) * 2024-01-31 2024-05-10 四川鲁徽制药有限责任公司 一种达格列净、吡格列酮复方缓释片及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds
GB9619757D0 (en) * 1996-09-21 1996-11-06 Knoll Ag Chemical process
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
US20020006939A1 (en) * 1997-10-13 2002-01-17 Smithkline Beecham P.L.C. Use of thiazolidinediones for the treatment of hyperglycaemia
DE69917618T2 (de) * 1998-04-03 2005-06-23 Egalet A/S Zusammensetzung mit kontrollierter wirkstoff-freisetzung
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
UA67802C2 (uk) * 1998-10-23 2004-07-15 Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
ATE315629T1 (de) * 1998-11-10 2006-02-15 Procter & Gamble Bleichmittelzusammensetzungen
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
EA007610B1 (ru) * 1998-11-12 2006-12-29 Смитклайн Бичам Плс Таблетка с энтеропокрытием, обеспечивающая отсроченное высвобождение
AU1403501A (en) * 1999-11-16 2001-05-30 Smithkline Beecham Plc Novel composition and use
DE60129425T2 (de) * 2000-05-01 2008-04-17 Aeropharm Technology LLC, Dover Kernformulierung
GB0027471D0 (en) * 2000-11-08 2000-12-27 Smithkline Beecham Plc Processes
GB0120835D0 (en) * 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
GB0127805D0 (en) * 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition
MY139719A (en) * 2002-02-12 2009-10-30 Glaxo Group Ltd Oral dosage form for controlled drug release
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Also Published As

Publication number Publication date
JP4714147B2 (ja) 2011-06-29
GB0318824D0 (en) 2003-09-10
UY28461A1 (es) 2005-03-31
EP1663191B1 (en) 2010-01-20
BRPI0413419A (pt) 2006-10-10
SG165178A1 (en) 2010-10-28
EP1663191A1 (en) 2006-06-07
EA011550B1 (ru) 2009-04-28
SI1663191T1 (sl) 2010-05-31
IL173177A0 (en) 2006-06-11
TW200517146A (en) 2005-06-01
CN1835741A (zh) 2006-09-20
ES2339554T3 (es) 2010-05-21
AU2004262933A1 (en) 2005-02-17
PL1663191T3 (pl) 2010-06-30
OA13233A (en) 2006-12-13
DK1663191T3 (da) 2010-04-26
MA27996A1 (fr) 2006-07-03
ECSP066338A (es) 2006-07-28
KR20060071396A (ko) 2006-06-26
MY151053A (en) 2014-03-31
NZ544632A (en) 2009-03-31
MXPA06001629A (es) 2006-04-28
PT1663191E (pt) 2010-03-16
EA200800966A1 (ru) 2009-04-28
HRP20100160T1 (hr) 2010-05-31
AR045230A1 (es) 2005-10-19
JP2007501830A (ja) 2007-02-01
ATE455542T1 (de) 2010-02-15
CA2534480A1 (en) 2005-02-17
EA200600400A1 (ru) 2006-08-25
PE20050357A1 (es) 2005-06-01
UA82537C2 (uk) 2008-04-25
AP2006003489A0 (en) 2006-02-28
AU2004262933B2 (en) 2009-12-10
US20080206336A1 (en) 2008-08-28
DE602004025257D1 (de) 2010-03-11
HK1092051A1 (en) 2007-02-02
CY1109923T1 (el) 2014-09-10
IS2745B (is) 2011-08-15
CN102397551A (zh) 2012-04-04
WO2005013956A1 (en) 2005-02-17
CN1835741B (zh) 2011-12-14
NO20061161L (no) 2006-03-10

Similar Documents

Publication Publication Date Title
GB2397837B (en) Single-direction cementing plug
NO20034688L (no) Multi-syklus tommeventil
EP1550657A4 (en) AMINO COMPOUNDS AND THEIR USE
EP1663366A4 (en) MASK
IS8181A (is) Efnablanda sem felur í sér PDE4 tálma og PDE5 tálma
EP1614719A4 (en) AZOVER BINDING AND SALT THEREOF
GB0325099D0 (en) Manufacture of a semi-conductor device
IS8337A (is) Efnablanda sem felur í sér rósiglítasón og metformín
FR2842459B1 (fr) Reliure a anneaux
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
GB0206415D0 (en) Deracemisation of amines
PT1631575E (pt) NOVOS DERIVADOS 3- DECLADINOSIL 9ª-N-CARBAMOIL E 9ª-N- TIOCARBAMOIL DE 9-DESOXI-9-DI-HIDRO-9ª-AZA-9ª-HOMOERITROMICINA
AU2003295211A8 (en) Rotary chain vice
UA8001S (uk) Штемпель кишеньковий
AU2003228072A8 (en) A new family of picornaviruses
IS7855A (is) Aðferð til að auka fiskveiði í sjó
GB0219365D0 (en) A vice
PL362942A1 (en) A strip of geo-composite
SE0202115D0 (sv) Use of a composition
AU153057S (en) A set of jewellery
AU153862S (en) A set of jewellery
AU156281S (en) A set of jewellery
PL359076A1 (en) Mitecidal compound, particularly warroacidal in a form of a shaped element
AU155203S (en) A gemstone
AU154879S (en) A gemstone